1-2 of 2
Shean-sheng Wang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Anas Younes, MD, Joshua Brody, MD, Cecilia Carpio, MD, Armando Lopez-Guillermo, Dina Ben-Yehuda, MD, A. Burhan Ferhanoglu, MD, Arnon Nagler, MD, Muhit Ozcan, MD, Irit Avivi, MD, Francesc Bosch Albareda, MD PhD, María Dolores Caballero Barrigón, MD PhD, Aisha Masood, MD, Michael Streit, MD MBA, John Alvarez, MD PhD, Rob Ceulemans, MS, Behzad Kharabi Masouleh, MD, Sriram Balasubramanian, PhD, Michael Schaffer, PhD, Shean-Sheng Wang, PhD, Nele Fourneau, MD, Wojciech Jurczak, PhDMD
Journal: Blood
Blood (2017) 130 (Supplement 1): 833.
https://doi.org/10.1182/blood.V130.Suppl_1.833.833
Published: 2017
Journal Articles

Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study

Ajay K. Gopal, MD, Stephen J. Schuster, MD, Nathan Fowler, MD, Judith Trotman, MBChB, Georg Hess, MD, Jing-Zhou Hou, Abdulraheem Yacoub, MD, Michael Lill, MD BS, Peter Martin, MD, Umberto Vitolo, MD, Wojciech Jurczak, MD, James Morton, MBBS, BSc(MD, FRACP, FRCPA, Dzhelil Osmanov, MD, Gary J. Gartenberg, MD, Jessica Vermeulen, MD PhD, Sriram Balasubramanian, PhD, Shean-sheng Wang, PhD, Sanjay Deshpande, MD, Gilles A. Salles
Journal: Blood
Blood (2016) 128 (22): 1217.
https://doi.org/10.1182/blood.V128.22.1217.1217
Published: 2016